Household costs and catastrophic health expenditure from malaria in pregnancy in Western Kenya

Background

Malaria in pregnancy (MiP) imposes a substantial economic burden on households in sub-Saharan Africa. We estimated household costs of MiP and their distribution across wealth quintiles among HIV-uninfected pregnant women in western Kenya receiving intermittent preventive treatment (IPTp) with sulfadoxine-pyrimethamine (SP), dihydroartemisinin-piperaquine (DP), or dihydroartemisinin-piperaquine plus provider education.